Navigation Links
CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
Date:10/27/2011

HemoStase inventory that the Company did not believe it would be able to distribute.  

General, administrative, and marketing expenses for the third quarter of 2011 were $14.7 million compared to $11.4 million for the third quarter of 2010.  General, administrative, and marketing expenses for the third quarter of 2011 included approximately $1.1 million in costs related to the Company's business development activities, including the acquisition of Cardiogenesis.  

General, administrative, and marketing expenses for the first nine months of 2011 were $42.7 million compared to $36.9 million for the first nine months of 2010.  General, administrative, and marketing expenses for the first nine months of 2011 included approximately $4.1 million in costs related to the Company's acquisition of Cardiogenesis and other business development activities.  General, administrative, and marketing expenses for the first nine months of 2010 included approximately $542,000 in costs related to business development activities.

Research and development expenses were $1.7 million and $1.6 million for the third quarters of 2011 and 2010, respectively.  Research and development expenses were $5.1 million and $4.1 million for the first nine months of 2011 and 2010, respectively.  Research and development spending in 2011 was primarily focused on PerClot, SynerGraft® tissues and products, BioFoam® Surgical Matrix, and BioGlue.  

Acquired in-process research and development expense of $3.5 million in the third quarter of 2010 was related to an intangible asset for PerClot distribution and manufacturing rights in the U.S. and certain other countries in which PerClot does not have current regulatory approvals.  Therefore the cost allocated to the asset was expensed upon acquisition.

Other expense was $207,000 for the third quarter of 2011 compared to $3.3 million for the third quarter of 2010.  Other
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
2. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
3. CryoLife Reports Record Quarterly Revenues of $28.2 Million
4. CryoLife to Present at Upcoming Investor Conferences in New York
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife Provides Initial 2010 Financial Guidance
7. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
8. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
9. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
10. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
11. CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
(Date:9/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Valeant Pharmaceuticals International, will redeem all of the outstanding ... Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the " ... an irrevocable notice of redemption for the Notes. ... irrevocable notice of redemption with respect to the remaining ...
(Date:9/15/2014)... Sept. 15, 2014  Decision Resources Group,s ... 2014, finds that online information and other ... to differentiate their offering and support physicians. ... purchasing decisions rely on websites, mobile apps ... devices—and these physicians are looking to manufacturers ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
... , GLEN BURNIE, Md. , Feb. ... delivery provider of prescription medications and veterinary therapeutic and ... Health, opening up the full suite of Pfizer products ... Health is the world,s leader in the discovery, development ...
Cached Medicine Technology:Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2VetCentric Announces Partnership With Pfizer Animal Health 2
(Date:9/15/2014)... “Canada Gynecological Devices Market Outlook ... Canada Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), ...
(Date:9/15/2014)... In order to provide predictability and safety, ... to quantify, define and model medical practice. Defined as ... of medical care. , The Journal of BioAcoustic Biology ... the non-profit Institute of BioAcoustic Biology, located in Albany, ... be much more than a measurement tool; math, as ...
(Date:9/15/2014)... Florida is now one of several states holding “no ... test could be forced to undergo a mandatory blood test. ... more people from drinking and driving. , Federal government ... breathalyzer refusal. The new law is aimed to lower this ... , the new Florida law requires people to take a ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... The severe respiratory virus believed to have sickened hundreds ... now spread to the Northeast, health officials report. ... Friday more than a dozen cases of infection with ... with asthma. And on Saturday, the Connecticut Department ...
(Date:9/15/2014)... 15, 2014 (HealthDay News) -- Births of multiple babies ... death than singleton births, researchers report. The researchers ... vitro fertilization (IVF) could ease some of that burden. ... increased in tandem with births to older mothers and ... the University of New South Wales, Australia. Their ...
Breaking Medicine News(10 mins):Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... California will simultaneously open their doors,Wednesday to Trick or ... SAN DIEGO, Oct. 30 It,s not every ... don,t often,see miniature witches and 3-foot-tall bumblebees, and little ... But at more,than 150 nursing homes in California this ...
... Va.SNM, the worlds largest society for molecular imaging and ... in Tuesdays Roll Call urging Congress to fund basic ... future discoveries. Support DOE funding for nuclear medicine research, ... provides news of legislative and political interest to Capitol ...
... good responses in almost half of patients, study found , ... axitinib shows promise for treating people with what,s known as ... typically have a poor response to drug treatment. , Axitinib ... endothelial growth factor receptors 1, 2 and 3. , ...
... Ohio, Oct. 30 STERIS Corporation,(NYSE: STE ) ... ended September 30, 2007. Fiscal 2008 second quarter revenues,increased ... the second,quarter of fiscal 2007, primarily driven by growth ... quarter net income was $16.0 million, or $0.25 per,diluted ...
... Inc.,(Pink Sheets: HRAL) announced that it has received additional ... International, Inc.,(NYSE: WMT ), to open their ninth ... Wal-Mart Store #3195 located at 1070 Major,Mackenzie Drive in ... #7 Unit Y006A in Markham will both officially open ...
... Oct. 30 Anthera Pharmaceuticals,Inc., a privately held ... diseases, today announced,that Donald J. Santel has been ... experience in transforming early biotech startups into,commercial stage ... our pipeline,and move A-002 into large scale Phase ...
Cached Medicine News:Health News:Halloween Events Bring Young and Old Together for a Ghoulish Good Time 2Health News:SNM ad urges congress to fund nuclear medicine research 2Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
The best value and features offered in a complete EMR and Practice Management Solution...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... The MediNotes Content Department has worked ... comprehensive medical content library and exam templates ... Plus is one of the most flexible ... which will allow you to take the ...
Medicine Products: